Main issue is anemic growth on a quarterly basis ARR of $3.4m vs $3.3m on Q4 FY21 and cash receipts of $3.8m vs $3.94m. Hopefully this is a seasonal issue, but on this trajectory they will run out of cash before they grow into break even position.
- Forums
- ASX - By Stock
- RMY
- Ann: Quarterly business update and Appendix 4C
RMY
rma global limited
Add to My Watchlist
3.70%
!
2.6¢

Ann: Quarterly business update and Appendix 4C, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $17.93M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.6¢ | $13.78K | 506.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 176459 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 190897 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 457691 | 0.026 |
3 | 350000 | 0.025 |
1 | 200000 | 0.022 |
2 | 580000 | 0.021 |
1 | 50100 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 190897 | 1 |
0.030 | 430050 | 1 |
0.031 | 482607 | 2 |
0.033 | 350000 | 1 |
0.035 | 294117 | 1 |
Last trade - 11.27am 03/07/2025 (20 minute delay) ? |
Featured News
RMY (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online